Sign In
Buy CRMD
$8.23
+0.0600 (+0.734%)
At Close: Jun 03, 2026
Earnings Preview: CorMedix (CRMD) Q4 Earnings Expected to Decline
12:00am, Thursday, 05'th Mar 2020Riversedge Advisors, Llc Buys iShares Edge MSCI Min Vol Global, iShares Core MSCI Emerging ...
12:00am, Friday, 14'th Feb 2020
So far Tuesday, February 4, NASDAQ is up 2.55% and the S&P is up 1.73%. Let’s take a look at
CorMedix Approved to Sell $5.5 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program
09:19pm, Monday, 03'rd Feb 2020
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,
CorMedix Approved To Sell $5.5M Of NOL Tax Benefits Through New Jersey Economic Development Authority Program
09:19pm, Monday, 03'rd Feb 2020CorMedix Inc. Announces FDA Grant Of Rolling Review Of Neutrolin New Drug Application
01:16pm, Monday, 03'rd Feb 2020CorMedix Inc. Announces FDA Grant of Rolling Review of Neutrolin® New Drug Application
01:15pm, Monday, 03'rd Feb 2020
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,
Investors Who Bought CorMedix (NYSEMKT:CRMD) Shares Five Years Ago Are Now Down 59%
11:58am, Monday, 03'rd Feb 2020
While it may not be enough for some shareholders, we think it is good to see the CorMedix, Inc. (NYSEMKT:CRMD) share...
